Related Experiment Video
Updated: Jan 27, 2026

04:10
A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies
Published on: November 29, 2024
1.2K
Rabies pretravel vaccination
Philippe Gautret1, Philippe Parola
1Institut Hospitalo-Universitaire des Maladies Infectieuses et Tropicales, Hôpital Nord, Université d'Aix-Marseille, Marseille, France. philippe.gautret@club-internet.fr
Current Opinion in Infectious Diseases
|July 25, 2012
Summary
Most travelers exposed to rabies are bitten by dogs, often not during long trips. Increasing pretravel rabies vaccination, especially using cost-effective intradermal methods, is crucial for traveler safety.
Area of Science:
- Epidemiology
- Travel Medicine
- Infectious Diseases
Background:
- Rabies remains a significant public health concern globally.
- Travelers are at risk of exposure to rabies through animal bites.
- Pretravel vaccination coverage among travelers is suboptimal.
Purpose of the Study:
- To review recent epidemiological findings on rabies exposure and cases in travelers.
- To explore cost-effective strategies for enhancing pretravel rabies vaccination in travelers.
Main Methods:
- Systematic review of global data on rabies exposure in travelers.
- Analysis of risk factors, animal sources, and geographical prevalence.
- Evaluation of vaccination strategies and post-exposure prophylaxis.
Main Results:
- Dog bites are the primary cause of rabies exposure in travelers (51%).
- Risk factors include travel to Southeast Asia, India, and North Africa; young age; and tourism.
- Over 70% of travelers lack pretravel immunization and adequate post-injury care.
- Travel duration is not a significant risk factor for exposure.
Conclusions:
- Intradermal rabies vaccination is economical, safe, and immunogenic for travelers.
- A three-dose vaccination series provides long-lasting immunity, representing a valuable investment.
- Abbreviated vaccination schedules are available for last-minute travelers.
Related Concept Videos
Vaccinations
51.3K
Overview
51.3K
Cancer Vaccines
990
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
990

